Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
A CAUTI prevention bundle is a small, fixed set of practices applied together on every catheterized patient: use a urinary catheter only for an appropriate indication, insert it with aseptic technique, keep the drainage system closed and unobstructed, and review its need every day so it comes out as soon as the indication ends. The two current sources are the CDC/HICPAC 2009 guideline and the SHEA/IDSA/APIC/AHA/Joint Commission 2022 update, and a bundle turns their recommendations into measured, audited process steps.
For infection preventionists, patient-safety officers, quality directors, risk managers and nursing leadership, that shift from clinical guidance to a monitored program is the actual work of running a CAUTI bundle, and it is the focus of this guide. The individual elements are not new; what a bundle changes is compliance discipline. Each element is measured, documented and audited as a discrete process step instead of being assumed to happen because it is “standard practice.”
This page covers the bundle elements themselves and how to build a maintenance and audit checklist around them. It does not re-explain the NHSN surveillance definition (the catheter-day rule and the SUTI 1a/1b/2 and ABUTI criteria that determine whether a case counts as a reportable CAUTI); for that, see CAUTI: NHSN Surveillance Definition, SUTI Criteria, and Reporting. It also does not cover catheter type, size and material selection for procurement; for that buying-decision angle, see Urinary Catheter Types and Selection: A Clinical Buyer’s Guide.
Where to source this: CASRAI’s sister medical-supply business, LAC (lac.us), stocks indwelling catheters and closed-system drainage supplies for institutional buyers standardizing a formulary. For catheter and urology/incontinence supplies generally, see the Catheters, Urology & Incontinence category; for indwelling (Foley) catheters specifically, by French size and balloon volume, see Indwelling Catheters. For the selection logic between catheter types and sizes, see the dedicated buying guide linked above. This note is about sourcing the closed-system components a maintenance program depends on, not a substitute for that selection discussion.
Why a Bundle, Not a Checklist of Best Practices
CAUTI risk is driven overwhelmingly by one variable: catheter-days. Every day an indwelling urinary catheter remains in place is a day of continuous colonization risk, and the surveillance definition reflects that: NHSN’s CAUTI criteria only start applying once an indwelling catheter has been in place for more than two consecutive calendar days. A bundle rests on the same claim used for the analogous SSI prevention bundle: reliably performing several individually modest interventions together, on every eligible patient, is expected to reduce risk more than any one intervention performed inconsistently. For CAUTI there is one more layer. The single highest-leverage intervention is not a technique at all; it is not inserting the catheter, or removing it sooner.
Both guideline texts are organized in that order of leverage, and this guide follows it: appropriate use first, then insertion technique, then maintenance, then removal. The SHEA/IDSA/APIC/AHA/Joint Commission document “Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 Update” (Infection Control & Hospital Epidemiology, August 2023, 44(8):1209-31) replaces the 2014 compendium. It frames prevention across the catheter life cycle: step 0 appropriateness, step 1 insertion, step 2 maintenance, step 3 removal.
What Changed Between the CDC 2009 and SHEA 2022 Guidance
The 2009 CDC/HICPAC guideline grades each recommendation by category: IA (strong, high to moderate-quality evidence), IB (strong, low-quality evidence or accepted practice such as aseptic technique), IC (required by regulation) and II (weak). Its three priority modules, all graded IB, are appropriate use, aseptic insertion and maintenance with closed, unobstructed drainage. The 2022 update instead sorts practices into essential practices, additional approaches and approaches that should not be used, and attaches a quality-of-evidence grade (high, moderate or low) to each.
The data table below this guide compares fifteen practices side by side across the two documents. Three differences matter for program design:
- Smallest feasible catheter diameter. In the 2009 guideline this recommendation is category II (weak). The 2022 update lists it as an essential practice, with low-quality evidence. It should therefore not be described as optional.
- Infrastructure and organization-wide programs. The 2022 update adds a risk assessment and an organization-wide program to identify and remove unnecessary catheters (moderate evidence), plus explicit expectations for supplies and documentation fields that the 2009 text treated mainly as quality-improvement measures.
- Explicit “do not use” list. The 2022 update names approaches that should not be used, among them routine antimicrobial-impregnated catheters and screening for asymptomatic bacteriuria, each with high-quality evidence behind the recommendation.
Element 1: Appropriate-Use Criteria
The bundle element with the largest effect on catheter-days is the one applied before insertion: does this patient actually need an indwelling catheter? CDC/HICPAC (2009) lists these appropriate indications, graded as expert consensus:
- Acute urinary retention or bladder outlet obstruction
- Accurate measurement of urinary output in critically ill patients
- Perioperative use for selected surgical procedures: urologic or contiguous-structure surgery, prolonged surgery (the catheter is removed in the post-anesthesia care unit), large-volume infusion or diuretics, and intraoperative urinary output monitoring
- Assisting healing of open sacral or perineal wounds in incontinent patients
- Prolonged immobilization (for example an unstable spine or pelvic fractures)
- Comfort care at end of life
The same guideline names uses that are not appropriate on their own: a substitute for nursing care of incontinence, obtaining urine for culture when the patient can void, and prolonged postoperative use without an indication. It also advises avoiding catheters for incontinence and removing postoperative catheters preferably within 24 hours unless an indication remains.
Operational thresholds in the 2022 update
The 2022 update gives examples of appropriate indications that make the criteria easier to audit. Acute retention is defined by bladder-scanner post-void residual: more than 500 cm3 if the patient is asymptomatic, or more than 300 cm3 if symptomatic. ICU care by itself is not an indication. A catheter placed intraoperatively only for the duration of the procedure (the example given is a case of more than 3 hours) should be removed at the end of the case.
Alternatives to an indwelling catheter
CDC/HICPAC (2009) suggests external catheters in cooperative men without urinary retention or bladder outlet obstruction, and intermittent catheterization for patients with spinal cord injury or bladder-emptying dysfunction (both category II). Where a bladder scanner is used to avoid catheterization, the guideline specifies that indications are stated, staff are trained and the scanner is disinfected between patients (category IB). A formulary or order set that lists the appropriate indications, and requires the ordering clinician to select one before the order can be placed, is the practical mechanism that turns this element into an audit trail.
Supplies and infrastructure
The 2022 update treats supplies as part of the bundle: bladder scanners, urinals, garments and bed pads, male and female external catheters, straight (intermittent) catheters and coudé-tip indwelling catheters. Non-catheter supplies should be as easy to obtain as indwelling catheters; otherwise staff default to the catheter. CDC/HICPAC (2009) likewise recommends that supplies for aseptic insertion are readily available (category IB).
Element 2: Aseptic Insertion Technique
Once appropriate use is established, insertion is a sterile procedure. In acute care, CDC/HICPAC (2009) calls for aseptic technique and sterile equipment: hand hygiene immediately before insertion, gloves, drape, sponges, an appropriate antiseptic solution for periurethral cleaning and a single-use packet of lubricant. The guideline also calls for the smallest catheter consistent with good drainage to minimize urethral trauma. As noted above, that last point is graded weak (category II) in 2009 but is an essential practice in the 2022 update.
Insertion should be performed only by personnel who are trained and have had their competency assessed; the 2022 update also expects supervision of trainees. Proper securement immediately after insertion (a stabilization device or tape anchoring the catheter to the leg) prevents urethral traction and movement, which is itself a maintenance-phase risk factor and not only a comfort issue.
Several insertion questions remain open in the 2022 update. Chlorhexidine is described as an emerging option for meatal cleaning, alcohol-based products are to be avoided on mucosa, and whether an antiseptic is better than sterile saline is listed as unresolved. The update also suggests facilities consider having two staff members work in pairs at insertion.
Intermittent catheterization needs a setting-specific reading. CDC/HICPAC (2009) calls for aseptic technique in acute care; clean technique is acceptable for chronic intermittent catheterization in non-acute settings (category IA).
Element 3: Maintaining Closed Drainage System Integrity
The maintenance elements exist because an intact closed system is the primary barrier to organisms reaching the bladder after insertion. The core maintenance requirements:
- Maintain a sterile, continuously closed drainage system. If a break in aseptic technique, a disconnection or leakage occurs, replace the catheter and the collecting system using aseptic technique and sterile equipment (category IB). Any break is a documented event, not a routine occurrence.
- Keep the collection bag below the level of the bladder at all times and off the floor to preserve unobstructed, gravity-dependent drainage. See types of catheter bags for how bag designs differ.
- Keep tubing free of kinks and dependent loops that trap urine and interrupt flow.
- Empty the collection bag regularly using a clean, separate container for each patient, with the drainage spigot not contacting the container. Apply standard precautions (see standard precautions and infection control).
- Obtain specimens through the needleless sampling port after disinfecting it, rather than disconnecting the system.
- Secure the catheter to prevent movement and urethral traction for the whole dwell time, not just at insertion.
Specimen handling
The 2022 update advises that urine specimens reach the laboratory preferably within one hour; otherwise they should be refrigerated (for up to 24 hours) or collected in preservative tubes, so that culture results reflect the patient and not bacterial growth in the container.
Approaches that should not be used
CDC/HICPAC (2009) and the 2022 update agree that several common habits do not reduce CAUTI risk and should not be part of a bundle:
- Routine bladder irrigation. The 2009 guideline does not recommend it unless obstruction is anticipated, in which case closed continuous irrigation is used; the 2022 update rates the evidence against it as moderate. Instilling antimicrobials into drainage bags is also not recommended.
- Cleaning the periurethral area with antiseptics while the catheter is in place. Routine hygiene, such as cleaning the meatal surface during daily bathing, is fine.
- Routine catheter changes at fixed intervals. If a long-term catheter has been in more than 7 days, the 2022 update says replacement can be considered when a specimen is collected.
- Routine systemic antimicrobial prophylaxis.
- Clamping the catheter before removal, which is unnecessary (category II).
- Routine antimicrobial or antiseptic-impregnated catheters. CDC/HICPAC (2009) says to consider them only if the CAUTI rate is not falling after a comprehensive strategy; the 2022 update lists them as an approach that should not be used routinely, with high-quality evidence.
- Breaking the closed system, and using alcohol-based products on mucosa.
The 2022 update also lists questions it considers unresolved: antiseptic versus saline at insertion, methenamine, spatial separation of catheterized patients, routine replacement beyond 30 days, and adaptation to pediatric patients.
Element 4: Daily Necessity Review and Prompt Removal
Because catheter-days drive risk, the element that most directly controls it is a standing, documented review of whether the catheter is still indicated, performed daily and not left to whoever happens to notice. Both guidelines list the same quality-improvement tools: alerts and reminders, nurse-directed removal protocols, education with performance feedback, perioperative algorithms, and postoperative retention protocols that use bladder scanners.
The 2022 update’s essential practices spell out what daily review means: daily review of catheter need, electronic reminders, and review during daily rounds by nursing and physicians. It suggests facilities consider a nurse-driven removal protocol for the first trial of voiding: a standing order, approved by medical staff and nursing leadership, that authorizes nurses to remove the catheter once none of the documented indications still applies, without waiting for a new physician order. Where a full protocol is not in place, a charted daily necessity check against the same indication list used at insertion is the minimum version of this element.
Documentation fields that make the review auditable
The 2022 update expects the record to show: the order, the indication, insertion date and time, who inserted the catheter, daily presence and the maintenance tasks performed, removal date and time, and the removal criteria or justification. CDC/HICPAC (2009) lists documentation of the indication, insertion date and time, inserter and removal date and time as category II. Without these fields none of the process measures below can be calculated.
Urine Culture Stewardship and Asymptomatic Bacteriuria
Prevention also depends on what happens when someone considers sending a urine culture. The 2022 update lists urine-culture stewardship, meaning standardized indications for cultures, among its essential practices. Screening catheterized patients for asymptomatic bacteriuria is an approach that should not be used (high-quality evidence), with exceptions for pregnant women and for patients about to undergo endoscopic urologic procedures with expected mucosal trauma. CDC/HICPAC (2009) likewise does not recommend routine screening (category II). The difference between symptomatic and asymptomatic bacteriuria in surveillance terms is covered in the CAUTI surveillance guide.
The CAUTI Bundle Checklist
Consolidated across the four elements, a working insertion-and-maintenance checklist:
- Before insertion: a documented appropriate-use indication is charted; alternatives (scheduled toileting, external catheter, intermittent catheterization, bladder scanning) were considered and ruled out where applicable; non-catheter supplies were available.
- At insertion: trained, competency-assessed staff; hand hygiene performed; aseptic technique with sterile equipment throughout; smallest feasible catheter size selected; catheter secured to prevent traction; date, time, inserter and indication documented.
- Daily, while in place: closed system intact (no unplanned disconnections); bag below bladder level and off the floor; tubing free of kinks and dependent loops; securement in place; bag emptied per protocol with a clean container; continued necessity reviewed and charted against the same indication list.
- At removal: catheter discontinued as soon as no qualifying indication remains, per the nurse-driven protocol or physician order; removal date, time and reason documented.
Measuring and Auditing Bundle Compliance
As with the SSI bundle, a bundle is a measured program, not a poster on the unit wall. Each element needs a metric with a defined numerator and denominator.
Process measures
The CDC’s implementation and audit guidance defines process measures, each expressed as a percentage (multiplied by 100): compliance with training of staff who insert catheters; documentation of insertion and removal dates; and documentation of the indication for catheterization. Add the 2022 update’s extra elements where relevant: daily necessity review documented, and closed-system breaches tracked as their own event.
Outcome and utilization measures
| Measure | Definition | What it tells you |
|---|---|---|
| Catheter utilization ratio | (urinary catheter days / patient days) × 100 (CDC) | How much catheter exposure a unit has; fed back to units quarterly (category II) |
| CAUTI rate | CAUTI per 1,000 catheter-days (CDC) | Infection outcome; secondary bloodstream infections are tracked per 1,000 catheter-days |
| Standardized utilization ratio (SUR) | Observed / predicted device days (2022 update); CAUTI baseline year 2015 | Utilization compared with NHSN’s risk-adjusted prediction |
| Standardized infection ratio (SIR) | Observed / predicted CAUTI (see standardized infection ratio) | Infection outcome compared with the NHSN baseline |
The 2022 update explains how to read SIR and SUR together. A low SIR with a high SUR may reflect strict culture practice, so the focus should be reducing utilization. A high SIR with a low SUR points toward maintenance practices and culture stewardship. The SUR may suit smaller hospitals better than the SIR. These are reported through NHSN to infection prevention and quality committees on a recurring cadence.
Catheter harm metrics
Catheters carry harms besides infection: urethral inflammation, strictures, trauma and impaired mobility. The 2022 update suggests surveillance of catheter use and harm, including obstruction, unintended removal, trauma and reinsertion within 24 hours of removal, and surveillance of non-catheter-associated UTIs, for example in patients with external catheters, who fall outside the NHSN CAUTI definition.
Implementation Pitfalls and What the Studies Show
The 2022 update reports published outcomes of bundle programs; these are results of particular studies and not promises for any facility:
- A single-center neuro-ICU bundle lowered catheter utilization from 100% to 73% and CAUTI from 13.3 to 4.0 per 1,000 catheter-days.
- In seven Veterans Affairs hospitals, medical-surgical unit CAUTI fell from 2.4 to 0.8 per 1,000 catheter-days (P = .001), with no significant change in ICUs. The ICU gap is a reminder that culture practices and critical-care workflows may need a separate approach.
- An AHRQ long-term care program was associated with a 54% reduction in CAUTI and a 15% reduction in culture orders.
For context, the 2022 update cites a 2020 NHSN rate of 0.754 CAUTI per 1,000 catheter-days across adult inpatient units, and earlier adult ICU rates ranging from 1.2 to 4.5. Reporting of CAUTI by ICUs to NHSN began in January 2012 under the CMS inpatient prospective payment system FY2012 final rule. Common pitfalls follow from the above: a daily review that is not charted, supplies for alternatives stored where nobody can find them, and treating the bundle as an insertion checklist while removal and culture practices go unmeasured. Related bundles with the same compliance logic include catheter-related bloodstream infection prevention.
Frequently Asked Questions
What are the elements of a CAUTI prevention bundle?
Appropriate-use criteria before insertion, aseptic insertion by trained staff, maintenance of a closed and unobstructed drainage system, and daily review of continued necessity with prompt removal, supported by documentation and audit.
What is the single most effective element?
Avoiding unnecessary catheterization and removing catheters as soon as they are no longer indicated. Because CAUTI risk accumulates with catheter-days, appropriate-use criteria at insertion and a nurse-driven removal protocol at the other end act on the denominator (catheter-days) more than any maintenance technique acts on the numerator.
How many days can a Foley catheter stay in?
There is no fixed number in the guidelines. A catheter stays only as long as an appropriate indication remains, and it is reviewed daily. Routine changes at fixed intervals are not recommended.
What is the difference between the CDC 2009 and SHEA 2022 recommendations?
The 2009 guideline uses evidence categories (IA, IB, IC, II); the 2022 update uses essential practices, additional approaches and approaches that should not be used, with a quality-of-evidence grade. Smallest feasible catheter diameter is category II in 2009 but an essential practice in 2022. The data table compares fifteen practices.
What are acceptable indications for an indwelling catheter?
Acute retention or outlet obstruction, urine output measurement in the critically ill, selected perioperative uses, open sacral or perineal wounds in incontinent patients, prolonged immobilization and end-of-life comfort. ICU care alone is not an indication.
Should the catheter be changed routinely?
No. Fixed-interval changes are not recommended. The 2022 update notes that for a long-term catheter in place more than 7 days, replacement can be considered when a specimen is collected.
Is screening or treating asymptomatic bacteriuria part of CAUTI prevention?
No. Screening is an approach that should not be used, except in pregnant women and before endoscopic urologic procedures with mucosal trauma.
How do you calculate catheter utilization ratio and SUR?
Catheter utilization ratio is urinary catheter days divided by patient days, times 100. The SUR is observed device days divided by predicted device days from NHSN.
Do antimicrobial-impregnated catheters reduce CAUTI?
They are not recommended routinely (high-quality evidence). CDC/HICPAC (2009) would consider them only if rates are not falling after a comprehensive strategy.
Do external catheters count in CAUTI surveillance?
They are not part of the NHSN CAUTI definition, which covers indwelling catheters. The 2022 update suggests tracking non-catheter-associated UTIs separately.
Who may insert a catheter?
Only trained personnel whose competency has been assessed, with supervision of trainees.
Does a CAUTI bundle replace the NHSN surveillance definition?
No. The bundle is a set of practices intended to prevent infections; the NHSN definition is how a case is counted. See CAUTI: NHSN Surveillance Definition, SUTI Criteria, and Reporting. For catheter types see the catheter selection guide, and for lubricant questions see catheter lubricant.
Sources
Sources (accessed 2026-11-16):
- CDC/HICPAC, Guideline for Prevention of Catheter-Associated Urinary Tract Infections (2009): https://www.cdc.gov/infection-control/hcp/cauti/index.html
- CDC, CAUTI implementation and audit page: https://www.cdc.gov/infection-control/hcp/cauti/implementation-and-audit.html
- Patel et al., Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 Update, Infection Control & Hospital Epidemiology 2023: https://pmc.ncbi.nlm.nih.gov/articles/PMC11287483/
This guide summarizes CAUTI prevention practices as organized in CDC/HICPAC and SHEA/IDSA/APIC infection-prevention guidance, for general orientation. It is not a substitute for a facility’s own infection-prevention policy, the current guideline text, or clinical judgment in an individual case. Related: see the Patient Safety & Infection Prevention hub, the CAUTI surveillance definition guide, the urinary catheter buying guide, and the SSI prevention bundle guide.
Data: CAUTI prevention practices: CDC/HICPAC 2009 category versus SHEA/IDSA/APIC 2022 classification and evidence quality
Compares how fifteen CAUTI prevention practices are rated in the CDC/HICPAC 2009 guideline (recommendation category) and in the 2022 SHEA/IDSA/APIC Compendium update (essential practice or approach that should not be used, with the panel's quality-of-evidence grade). Compiled by matching each practice across the two guideline texts; the wording of some practices is condensed.
Period covered: 2009/2023. Coverage: United States.
| Practice | CDC/HICPAC 2009 category | SHEA/IDSA/APIC 2022 classification | SHEA 2022 quality of evidence |
|---|---|---|---|
| Insert only when necessary; remove when indication ends | IB | Essential practice | Moderate |
| Periodic (usually daily) review of need for continued catheter | IB (QI purpose: daily review of continued need) | Essential practice | Moderate |
| Hand hygiene immediately before insertion and around manipulation | IB | Essential practice | Low |
| Aseptic technique with sterile equipment at insertion | IB | Essential practice | Low |
| Smallest feasible catheter diameter consistent with drainage | II | Essential practice | Low |
| Secure catheter to prevent movement and urethral traction | IB | Essential practice | Low |
| Maintain a sterile, continuously closed drainage system | IB | Essential practice | Low |
| Replace catheter and collecting system if closed system is breached | IB | Essential practice | Low |
| Bag below bladder level, off the floor, tubing free of kinks | IB | Essential practice | Low |
| Only trained staff insert; competency assessed | IB (trained persons) | Essential practice | Low |
| Routine antimicrobial or antiseptic-impregnated catheters | IB (consider only if rate not falling after a comprehensive strategy) | Approach that should not be used | High |
| Catheter irrigation as an infection-prevention strategy | II (not recommended unless obstruction anticipated) | Approach that should not be used | Moderate |
| Routine systemic antimicrobial prophylaxis | IB (not routine) | Approach that should not be used | Low |
| Routine catheter changes at fixed intervals | II (not recommended) | Approach that should not be used | Low |
| Screening catheterized patients for asymptomatic bacteriuria | II (not recommended) | Approach that should not be used | High |
Sources
- Guideline for Prevention of Catheter-Associated Urinary Tract Infections (2009), CDC/HICPAC (accessed 2026-11-16)
- Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 Update (Patel et al., ICHE 2023) (accessed 2026-11-16)
Compiled by CASRAI from the sources above. Free to reuse under CC BY 4.0 with attribution.







